Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
N.N. Youssef
ResearcherPublications, citations & collaboration network
N.N. Youssef is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 4 works, 1 citations, an h-index of 1 and an i10-index of 0.
4
Works
1
Citations
1
h-index
0
i10-index
IDs:OpenAlex
How has N.N. Youssef's publication output changed over time?
ScholarIQpublication output · 2023–2024
Output grew200% over the shown period — from 1 works in 2023 to 3 in 2024.
1
3
20232024
What are the most-cited papers on N.N. Youssef?
ScholarIQmost cited works
Efficacy and safety of apraglutide once-weekly in patients with Short Bowel Syndrome and Intestinal Failure (SBS-IF): results from the stars study - a global phase 3 double-blind, randomized, placebo-controlled trial
F. Joly, Tim Vanuytsel, Donald F. Kirby, Simon Lal, Kelly A. Tappenden, Palle Bekker Jeppesen, N.N. Youssef, Chong Li, Reda Sheik, Isabelle Statovci, Sung‐Young Huh, Federico Bolognani, Kishore Iyer
Clinical Nutrition ESPEN. 20241 Citations
Unmet Medical Needs In Short Bowel Syndrome With Intestinal Failure Identified From A Qualitative Survey Of Patients And Healthcare Providers
D. Wolin, K. Kosa, N.N. Youssef, L. Zografos
Clinical Nutrition ESPEN. 20230 CitationsOPEN ACCESS
Increased oral intake and improved energy and carbohydrate absorption at 48 weeks with apraglutide in short bowel syndrome with intestinal failure (SBS-IF) and colon-in-continuity (CIC)
Astrid Verbiest, Mark Hvistendahl, Federico Bolognani, Chuang Li, N.N. Youssef, Francisca Joly, P.B. Jeppesen, Tim Vanuytsel
Clinical Nutrition ESPEN. 20240 Citations
Apraglutide results in reduced Parenteral Support (PS) needs and improved patient reported outcomes in Short Bowel Syndrome with Intestinal Failure (SBS-IF) and Colon-in-Continuity (CiC)
Astrid Verbiest, Mark Hvistendahl, Federico Bolognani, Chuang Li, N.N. Youssef, P.B. Jeppesen, Francisca Joly, T. Vanuytsel
Clinical Nutrition ESPEN. 20240 Citations
Related on ScholarIQ
Efficacy and safety of apraglutide once-weekly in patients with Short Bowel Syndrome and Intestinal Failure (SBS-IF): results from the stars study - a global phase 3 double-blind, randomized, placebo-controlled trial
Paper
Unmet Medical Needs In Short Bowel Syndrome With Intestinal Failure Identified From A Qualitative Survey Of Patients And Healthcare Providers
Paper
Increased oral intake and improved energy and carbohydrate absorption at 48 weeks with apraglutide in short bowel syndrome with intestinal failure (SBS-IF) and colon-in-continuity (CIC)
Paper
Apraglutide results in reduced Parenteral Support (PS) needs and improved patient reported outcomes in Short Bowel Syndrome with Intestinal Failure (SBS-IF) and Colon-in-Continuity (CiC)
Paper
Clinical Nutrition and Gastroenterology
Topic
Electrolyte and hormonal disorders
Topic